Frizzled-8 receptor is activated by the Wnt-2 ligand in non-small cell lung cancer

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Bravo, Dawn T ^a   Yang, Yi Lin ^a   Kuchenbecker, Kristopher ^a   Hung, Ming Szu ^a   Xu, Zhidong ^a   Jablons, David M ^a   You, Liang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

dnhWnt 2 Construct; Frizzled 8; Lung Cancer; Wnt Signaling; Wnt 2

Indexed keywords

BETA CATENIN; CYCLIN D1; DISHEVELLED PROTEIN; FRIZZLED 8 PROTEIN; FRIZZLED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MYC PROTEIN; SURVIVIN; UNCLASSIFIED DRUG; WNT2 PROTEIN; LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION; ANIMAL; DISEASE MODEL; DRUG SCREENING; LUNG TUMOR; METABOLISM; NON SMALL CELL LUNG CANCER; NUDE MOUSE; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE MODELS, ANIMAL; FEMALE; FRIZZLED RECEPTORS; HUMANS; LIGANDS; LUNG NEOPLASMS; MICE; MICE, NUDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WNT2 PROTEIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84879492670     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-316     Document Type: Article

References (59)

1. Maslyar DJ, Jahan TM, Jablons DM. Mechanisms of and potential treatment strategies for metastatic disease in non-small cell lung cancer. Semin Thorac Cardiovasc Surg 2004, 16(1):40-50. 10.1053/j.semtcvs.2003.12.003, 15366686.
2. Smith W, Khuri FR. The care of the lung cancer patient in the 21st century: a new age. Semin Oncol 2004, 31(2 Suppl 4):11-15.
3. Adesina AM, Lopez-Terrada D, Wong KK, Gunaratne P, Nguyen Y, Pulliam J, Margolin J, Finegold MJ. Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways. Hum Pathol 2009, 40(6):843-853. 10.1016/j.humpath.2008.10.022, 2957366, 19200578.
4. Dann CE, Hsieh JC, Rattner A, Sharma D, Nathans J, Leahy DJ. Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature 2001, 412(6842):86-90. 10.1038/35083601, 11452312.
5. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A 1995, 92(7):3046-3050. 10.1073/pnas.92.7.3046, 42356, 7708772.
6. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108(6):837-847. 10.1016/S0092-8674(02)00685-2, 11955436.
7. Sakanaka C, Leong P, Xu L, Harrison SD, Williams LT. Casein kinase iepsilon in the wnt pathway: regulation of beta-catenin function. Proc Natl Acad Sci U S A 1999, 96(22):12548-12552. 10.1073/pnas.96.22.12548, 22983, 10535959.
8. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature 2000, 407(6803):535-538. 10.1038/35035124, 11029008.
9. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y, Hess F, Saint-Jeannet JP, He X. LDL-receptor-related proteins in Wnt signal transduction. Nature 2000, 407(6803):530-535. 10.1038/35035117, 11029007.
10. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A 1998, 95(15):8847-8851. 10.1073/pnas.95.15.8847, 21165, 9671767.
11. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 1996, 382(6592):638-642. 10.1038/382638a0, 8757136.
12. Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG, Kemler R. Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev 1996, 59(1):3-10. 10.1016/0925-4773(96)00597-7, 8892228.
13. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. Identification of c-MYC as a target of the APC pathway. Science 1998, 281(5382):1509-1512.
14. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398(6726):422-426. 10.1038/18884, 10201372.
15. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998, 14:59-88. 10.1146/annurev.cellbio.14.1.59, 9891778.
16. Shimizu H, Julius MA, Giarre M, Zheng Z, Brown AM, Kitajewski J. Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ 1997, 8(12):1349-1358.
17. Caldwell GM, Jones C, Gensberg K, Jan S, Hardy RG, Byrd P, Chughtai S, Wallis Y, Matthews GM, Morton DG. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res 2004, 64(3):883-888. 10.1158/0008-5472.CAN-03-1346, 14871816.
18. Lin YC, You L, Xu Z, He B, Yang CT, Chen JK, Mikami I, Clement G, Shi Y, Kuchenbecker K, et al. Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth. Human gene therapy 2007, 18(4):379-386. 10.1089/hum.2006.005, 17472570.
19. Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, Sasaki S, Takagi H, Sogabe Y, Sasaki Y, Idogawa M, et al. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis 2007, 28(12):2459-2466. 10.1093/carcin/bgm178, 17675336.
20. Polakis P. The many ways of Wnt in cancer. Curr Opin Genet Dev 2007, 17(1):45-51. 10.1016/j.gde.2006.12.007, 17208432.
21. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005, 434(7035):843-850. 10.1038/nature03319, 15829953.
22. Takebe N, Harris PJ, Warren RQ, Ivy SP. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nature Reviews Clinical Oncology 2011, 8(2):97-106. 10.1038/nrclinonc.2010.196, 21151206.
23. Mazieres J, He B, You L, Xu Z, Jablons DM. Wnt signaling in lung cancer. Cancer Lett 2005, 222(1):1-10. 10.1016/j.canlet.2004.08.040, 15837535.
24. Van Scoyk M, Randall J, Sergew A, Williams LM, Tennis M, Winn RA. Wnt signaling pathway and lung disease. Transl Res 2008, 151(4):175-180. 10.1016/j.trsl.2007.12.011, 18355764.
25. You L, He B, Xu Z, Uematsu K, Mazieres J, Mikami I, Reguart N, Moody TW, Kitajewski J, McCormick F, et al. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 2004, 23(36):6170-6174. 10.1038/sj.onc.1207844, 15208662.
26. He B, You L, Uematsu K, Xu Z, Lee AY, Matsangou M, McCormick F, Jablons DM. A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 2004, 6(1):7-14. 1508626, 15068666.
27. Winn RA, Marek L, Han SY, Rodriguez K, Rodriguez N, Hammond M, Van Scoyk M, Acosta H, Mirus J, Barry N, et al. Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation. J Biol Chem 2005, 280(20):19625-19634. 10.1074/jbc.M409392200, 15705594.
28. Uematsu K, He B, You L, Xu Z, McCormick F, Jablons DM. Activation of the Wnt pathway in non small cell lung cancer: evidence of dishevelled overexpression. Oncogene 2003, 22(46):7218-7221. 10.1038/sj.onc.1206817, 14562050.
29. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, Munemitsu S, Polakis P. Association of the APC gene product with beta-catenin. Science 1993, 262(5140):1731-1734. 10.1126/science.8259518, 8259518.
30. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993, 262(5140):1734-1737. 10.1126/science.8259519, 8259519.
31. Pongracz JE, Stockley RA. Wnt signalling in lung development and diseases. Respir Res 2006, 7:15. 10.1186/1465-9921-7-15, 1397816, 16438732.
32. Ueda M, Gemmill RM, West J, Winn R, Sugita M, Tanaka N, Ueki M, Drabkin HA. Mutations of the beta- and gamma-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br J Cancer 2001, 85(1):64-68. 10.1054/bjoc.2001.1863, 2363927, 11437403.
33. Sunaga N, Kohno T, Kolligs FT, Fearon ER, Saito R, Yokota J. Constitutive activation of the Wnt signaling pathway by CTNNB1 (beta-catenin) mutations in a subset of human lung adenocarcinoma. Genes Chromosomes Cancer 2001, 30(3):316-321. 10.1002/1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9, 11170292.
34. Fukui T, Kondo M, Ito G, Maeda O, Sato N, Yoshioka H, Yokoi K, Ueda Y, Shimokata K, Sekido Y. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer. Oncogene 2005, 24(41):6323-6327. 10.1038/sj.onc.1208777, 16007200.
35. Wissmann C, Wild PJ, Kaiser S, Roepcke S, Stoehr R, Woenckhaus M, Kristiansen G, Hsieh JC, Hofstaedter F, Hartmann A, et al. WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol 2003, 201(2):204-212. 10.1002/path.1449, 14517837.
36. Mazieres J, He B, You L, Xu Z, Lee AY, Mikami I, Reguart N, Rosell R, McCormick F, Jablons DM. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 2004, 64(14):4717-4720. 10.1158/0008-5472.CAN-04-1389, 15256437.
37. Kim J, You L, Xu Z, Kuchenbecker K, Raz D, He B, Jablons D. Wnt inhibitory factor inhibits lung cancer cell growth. J Thorac Cardiovasc Surg 2007, 133(3):733-737. 10.1016/j.jtcvs.2006.09.053, 17320573.
38. Uematsu K, Kanazawa S, You L, He B, Xu Z, Li K, Peterlin BM, McCormick F, Jablons DM. Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. Cancer Res 2003, 63(15):4547-4551.
39. Karasawa T, Yokokura H, Kitajewski J, Lombroso PJ. Frizzled-9 is activated by Wnt-2 and functions in Wnt/beta -catenin signaling. J Biol Chem 2002, 277(40):37479-37486. 10.1074/jbc.M205658200, 12138115.
40. Yu M, Ting DT, Stott SL, Wittner BS, Ozsolak F, Paul S, Ciciliano JC, Smas ME, Winokur D, Gilman AJ, et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 2012, 487(7408):510-513. 10.1038/nature11217, 3408856, 22763454.
41. Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG, Ladanyi M, Gerald WL, Massague J. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009, 138(1):51-62. 10.1016/j.cell.2009.04.030, 2742946, 19576624.
42. Hoppler S, Brown JD, Moon RT. Expression of a dominant-negative Wnt blocks induction of MyoD in Xenopus embryos. Genes Dev 1996, 10(21):2805-2817. 10.1101/gad.10.21.2805, 8946920.
43. Taketo MM. Shutting down Wnt signal-activated cancer. Nat Genet 2004, 36(4):320-322. 10.1038/ng0404-320, 15054482.
44. van Amerongen R. Alternative Wnt pathways and receptors. Cold Spring Harb Perspect Biol 2012, 4:a007914. 10.1101/cshperspect.a007914, 22935904.
45. Wang HQ, Xu ML, Ma J, Zhang Y, Xie CH. Frizzled-8 as a putative therapeutic target in human lung cancer. Biochem Biophys Res Commun 2012, 417(1):62-66. 10.1016/j.bbrc.2011.11.055, 22138402.
46. Winn RA, Van Scoyk M, Hammond M, Rodriguez K, Crossno JT, Heasley LE, Nemenoff RA. Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gamma. J Biol Chem 2006, 281(37):26943-26950. 10.1074/jbc.M604145200, 16835228.
47. David R. Developement: Strong bones: got FZD9?. Nat Rev Mol Cell Biol 2011, 12(5):280.
48. Ranheim EA, Kwan HC, Reya T, Wang YK, Weissman IL, Francke U. Frizzled 9 knock-out mice have abnormal B-cell development. Blood 2005, 105(6):2487-2494. 10.1182/blood-2004-06-2334, 15572594.
49. Zhao C, Aviles C, Abel RA, Almli CR, McQuillen P, Pleasure SJ. Hippocampal and visuospatial learning defects in mice with a deletion of frizzled 9, a gene in the Williams syndrome deletion interval. Development 2005, 132(12):2917-2927. 10.1242/dev.01871, 15930120.
50. Liu G, Bafico A, Aaronson SA. The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts. Mol Cell Biol 2005, 25(9):3475-3482. 10.1128/MCB.25.9.3475-3482.2005, 1084300, 15831454.
51. Green JL, La J, Yum KW, Desai P, Rodewald LW, Zhang X, Leblanc M, Nusse R, Lewis MT, Wahl GM. Paracrine Wnt signaling both promotes and inhibits human breast tumor growth. Proc Natl Acad Sci U S A 2013, 110(17):6991-6996. 10.1073/pnas.1303671110, 23559372.
52. Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, Berger AJ, Major MB, Hwang ST, Rimm DL, Moon RT. Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci U S A 2009, 106(4):1193-1198. 10.1073/pnas.0811902106, 2626610, 19144919.
53. Fujii N, You L, Xu Z, Uematsu K, Shan J, He B, Mikami I, Edmondson LR, Neale G, Zheng J, et al. An antagonist of dishevelled protein-protein interaction suppresses beta-catenin-dependent tumor cell growth. Cancer Res 2007, 67(2):573-579. 10.1158/0008-5472.CAN-06-2726, 17234765.
54. Shan J, Shi DL, Wang J, Zheng J. Identification of a specific inhibitor of the dishevelled PDZ domain. Biochemistry 2005, 44(47):15495-15503. 10.1021/bi0512602, 16300398.
55. Yoshizumi T, Ohta T, Ninomiya I, Terada I, Fushida S, Fujimura T, Nishimura G, Shimizu K, Yi S, Miwa K. Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects. Int J Oncol 2004, 25(3):631-639.
56. Kim MS, Kim SS, Ahn CH, Yoo NJ, Lee SH. Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability. Hum Pathol 2009, 40(1):58-64. 10.1016/j.humpath.2008.06.006, 18755497.
57. Martin V, Valencia A, Agirre X, Cervera J, San Jose-Eneriz E, Vilas-Zornoza A, Rodriguez-Otero P, Sanz MA, Herrera C, Torres A, et al. Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia. Cancer science 2010, 101(2):425-432. 10.1111/j.1349-7006.2009.01413.x, 19874313.
58. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol 2012, 13(1):27-38.
59. DeAlmeida VI, Miao L, Ernst JA, Koeppen H, Polakis P, Rubinfeld B. The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo. Cancer Res 2007, 67(11):5371-5379. 10.1158/0008-5472.CAN-07-0266, 17545618.